Nanomaterials in controlled drug release

Cytotechnology

Volumn 63, Issue 4, 2011, Pages 319-323

  Cai, Xin Jun ^a   Xu, Ying Ying ^a  

^a Integrated Chinese and Western Medicine Hospital of Zhejiang Province   (China)

Author keywords

Colloid; Drug delivery; Drug release; Gel; Nanomaterial; Nanoparticle; Self assembly

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

CONTROLLED DRUG RELEASE; DRUG ADMINISTRATION ROUTE; REVIEW; VIRUS;

EID: 80052509977     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-011-9366-5     Document Type: Review

References (49)

1. JJ Alexander WW Hauswirth 2008 Adeno-associated viral vectors and the retina Adv Exp Med Biol 613 121 128 10.1007/978-0-387-74904-4-13 1:CAS:528:DC%2BC3cXhtlejsrzI
2. AM Al-Ghananeem H Saeed R Florence RA Yokel AH Malkawi 2010 Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses J Drug Target 18 381 388 10.3109/10611860903483396 1:CAS:528:DC%2BC3cXls1Wqu78%3D
3. J Ali M Ali S Baboota JK Sahani C Ramassamy L Dao Bhavna 2010 Potential of nanoparticulate drug delivery systems by intranasal administration Curr Pharm Des 16 14 1644 1653 10.2174/138161210791164108 1:CAS:528:DC%2BC3cXmvFCntL0%3D
4. D Betbeder S Sperandio JP Latapie J de Nadai A Etienne JM Zajac B Francés 2000 Biovector nanoparticles improve antinociceptive efficacy of nasal morphine Pharm Res 17 743 748 10.1023/A:1007594602449 1:CAS:528: DC%2BD3cXlvVCgt78%3D (Pubitemid 30670641)
5. P Blasi A Schoubben S Giovagnoli C Rossi M Ricci 2009 Lipid nanoparticles for drug delivery to the brain: in vivo veritas J Biomed Nanotechnol 5 344 350 10.1166/jbn.2009.1043 1:CAS:528:DC%2BD1MXhtlKnu7vI
6. D Bok 2004 Gene therapy of retinal dystrophies: achievements, challenges and prospects Novartis Found Symp 255 4 12 10.1002/0470092645.ch2 1:CAS:528:DC%2BD2cXnsFOktr8%3D discussion -6, 177-178
7. PK Buch JW Bainbridge RR Ali 2008 AAV-mediated gene therapy for retinal disorders: from mouse to man Gene Ther 15 849 857 10.1038/gt.2008.66 1:CAS:528:DC%2BD1cXmtVamsbY%3D (Pubitemid 351712618)
8. Caruso G, Raudino G, Caffo M, Alafaci C, Granata F, Lucerna S, Salpietro FM, Tomasello F (2010) Nanotechnology platforms in diagnosis and treatment of primary brain tumors. Recent Pat Nanotechnol 4(2):119-124
9. S Charlton NS Jones SS Davis L Illum 2007 Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device Eur J Pharm Sci 30 295 302 10.1016/j.ejps.2006. 11.018 1:CAS:528:DC%2BD2sXitFyrsL8%3D
10. Chekhonin VP, Baklaushev VP, Iusubalieva GM (2009) Prospects for targeted therapy for gliomas. Vestn Ross Akad Med Nauk (4):30-42
11. JH Collier JS Rudra JZ Gasiorowski JP Jung 2010 Multi-component extracellular matrices based on peptide self-assembly Chem Soc Rev 39 3413 3424 10.1039/b914337h 1:CAS:528:DC%2BC3cXhtVehs73P
12. N Denora A Trapani V Laquintana A Lopedota G Trapani 2009 Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain Curr Top Med Chem 9 182 196 10.2174/156802609787521571 1:CAS:528:DC%2BD1MXkvVSgtb0%3D
13. RG Ellis-Behnke YX Liang DK Tay PW Kau GE Schneider S Zhang W Wu KF So 2006 Nano hemostat solution: immediate hemostasis at the nanoscale Nanomedicine 2 207 215 1:CAS:528:DC%2BD2sXmvVOrsg%3D%3D (Pubitemid 44895530)
14. RG Ellis-Behnke YX Liang SW You DK Tay S Zhang KF So GE Schneider 2006 Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision Proc Natl Acad Sci USA 103 5054 5059 10.1073/pnas.0600559103 1:CAS:528:DC%2BD28XjsVGlsbo%3D
15. RS Fisher J Ho 2002 Potential new methods for antiepileptic drug delivery CNS Drugs 16 579 593 10.2165/00023210-200216090-00001 1:CAS:528: DC%2BD38Xnt1arsbk%3D
16. SB Fonseca MP Pereira SO Kelley 2009 Recent advances in the use of cell-penetrating peptides for medical and biological applications Adv Drug Deliv Rev 61 953 964 10.1016/j.addr.2009.06.001 1:CAS:528:DC%2BD1MXht1Wrsb%2FN
17. JL Gilmore X Yi L Quan AV Kabanov 2008 Novel nanomaterials for clinical neuroscience J Neuroimmune Pharmacol 3 83 94 10.1007/s11481-007-9099-6
18. A Graf A McDowell T Rades 2009 Poly(alkylcyanoacrylate) nanoparticles for enhanced delivery of therapeutics-is there real potential? Expert Opin Drug Deliv 6 371 387 10.1517/17425240902870413 1:CAS:528:DC%2BD1MXkvFCju7k%3D
19. JC Grieger RJ Samulski 2005 Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications Adv Biochem Eng Biotechnol 99 119 145 1:CAS:528:DC%2BD28XjtFOqtrk%3D (Pubitemid 44617179)
20. J Guo H Su Y Zeng YX Liang WM Wong RG Ellis-Behnke KF So W Wu 2007 Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold Nanomedicine 3 311 321 1:CAS:528:DC%2BD1cXjtFGnsQ%3D%3D (Pubitemid 350199643)
21. Heilbronn R, Weger S (2010) Viral vectors for gene transfer: current status of gene therapeutics. Handb Exp Pharmacol (197):143-170
22. NT Huynh C Passirani P Saulnier JP Benoit 2009 Lipid nanocapsules: a new platform for nanomedicine Int J Pharm 379 201 209 10.1016/j.ijpharm.2009.04.026 1:CAS:528:DC%2BD1MXhtVKjsr%2FF
23. A Jatariu C Peptu M Popa A Indrei 2009 Micro- and nanoparticles-medical applications Rev Med Chir Soc Med Nat Iasi 113 1160 1169
24. VV Jogani PJ Shah P Mishra AK Mishra AR Misra 2008 Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting Alzheimer Dis Assoc Disord 22 116 124 10.1097/WAD.0b013e318157205b 1:CAS:528: DC%2BD1cXms1ymtrg%3D
25. Kateb B, Chiu K, Black KL, Yamamoto V, Khalsa B, Ljubimova JY, Ding H, Patil R, Portilla-Arias JA, Modo M, Moore DF, Farahani K, Okun MS, Prakash N, Neman J, Ahdoot D, Grundfest W, Nikzad S, Heiss JD (2010) Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage 54(Suppl 1):S106-S124
26. IP Kaur R Bhandari S Bhandari V Kakkar 2008 Potential of solid lipid nanoparticles in brain targeting J Control Release 127 97 109 10.1016/j.jconrel.2007.12.018 1:CAS:528:DC%2BD1cXkt1Ortbg%3D
27. NM Khalil RM Mainardes 2009 Colloidal polymeric nanoparticles and brain drug delivery Curr Drug Deliv 6 261 273 1:CAS:528:DC%2BD1MXotlCntbs%3D
28. J Kopecek J Yang 2009 Peptide-directed self-assembly of hydrogels Acta Biomater 5 805 816 10.1016/j.actbio.2008.10.001 1:CAS:528:DC%2BD1MXksF2qu7o%3D
29. M Kumar A Misra K Pathak 2009 Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery PDA J Pharm Sci Technol 63 501 511 1:CAS:528:DC%2BC3cXhsFCktLo%3D
30. PM Ling SW Cheung DK Tay RG Ellis-Behnke 2011 Using self-assembled nanomaterials to inhibit the formation of metastatic cancer stem cell colonies in vitro Cell Transplant 20 127 131 10.3727/096368910X532783
31. JY Ljubimova M Fujita AV Ljubimov VP Torchilin KL Black E Holler 2008 Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery Nanomedicine (Lond) 3 247 265 10.2217/17435889.3.2.247 1:CAS:528:DC%2BD1cXktFyjt7o%3D (Pubitemid 351611858)
32. KR Martin RL Klein HA Quigley 2002 Gene delivery to the eye using adeno-associated viral vectors Methods 28 267 275 10.1016/S1046-2023(02)00232-3 1:CAS:528:DC%2BD38Xot1KmsL0%3D (Pubitemid 35341091)
33. A Mistry SZ Glud J Kjems J Randel KA Howard S Stolnik L Illum 2009 Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium J Drug Target 17 543 552 10.1080/10611860903055470 1:CAS:528:DC%2BD1MXptVegtL4%3D
34. A Mistry S Stolnik L Illum 2009 Nanoparticles for direct nose-to-brain delivery of drugs Int J Pharm 379 146 157 10.1016/j.ijpharm.2009.06.019 1:CAS:528:DC%2BD1MXhtVaqs7vM
35. G Modi V Pillay YE Choonara 2010 Advances in the treatment of neurodegenerative disorders employing nanotechnology Ann N Y Acad Sci 1184 154 172 10.1111/j.1749-6632.2009.05108.x 1:CAS:528:DC%2BC3cXivVegtLg%3D
36. M Namdeo S Saxena R Tankhiwale M Bajpai YM Mohan SK Bajpai 2008 Magnetic nanoparticles for drug delivery applications J Nanosci Nanotechnol 8 3247 3271 10.1166/jnn.2008.399 1:CAS:528:DC%2BD1cXhtlKmsbrP
37. Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, Tokuhara D, Kurokawa S, Takahashi Y, Tsukada H, Kozaki S, Akiyoshi K, Kiyono H (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 9:572-578
38. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-445
39. MM Patel BR Goyal SV Bhadada JS Bhatt AF Amin 2009 Getting into the brain: approaches to enhance brain drug delivery CNS Drugs 23 35 58 10.2165/0023210-200923010-00003 1:CAS:528:DC%2BD1MXitFCmsb0%3D
40. EM Poeschla 2003 Non-primate lentiviral vectors Curr Opin Mol Ther 5 529 540 1:CAS:528:DC%2BD3sXptFKitLc%3D (Pubitemid 37304720)
41. JM Provenzale GA Silva 2009 Uses of nanoparticles for central nervous system imaging and therapy AJNR Am J Neuroradiol 30 1293 1301 10.3174/ajnr.A1590 1:STN:280:DC%2BD1MrksVWktg%3D%3D
42. S Shilpi A Jain Y Gupta SK Jain 2007 Colloidosomes: an emerging vesicular system in drug delivery Crit Rev Ther Drug Carrier Syst 24 361 391 1:CAS:528:DC%2BD1cXhvFGgtA%3D%3D
43. MM Sleeper LT Bish HL Sweeney 2009 Gene therapy in large animal models of human cardiovascular genetic disease ILAR J 50 199 205 1:CAS:528: DC%2BD1MXps1eksbY%3D
44. EM Surace A Auricchio 2003 Adeno-associated viral vectors for retinal gene transfer Prog Retin Eye Res 22 705 719 10.1016/S1350-9462(03)00052-1 1:CAS:528:DC%2BD3sXot1GlsLo%3D (Pubitemid 37298045)
45. EM Surace A Auricchio 2008 Versatility of AAV vectors for retinal gene transfer Vision Res 48 353 359 10.1016/j.visres.2007.07.027 1:CAS:528: DC%2BD1cXhtlOmt7s%3D (Pubitemid 351179513)
46. SS Suri H Fenniri B Singh 2007 Nanotechnology-based drug delivery systems J Occup Med Toxicol 2 16 10.1186/1745-6673-2-16 (Pubitemid 351205611)
47. G Tosi L Costantino B Ruozi F Forni MA Vandelli 2008 Polymeric nanoparticles for the drug delivery to the central nervous system Expert Opin Drug Deliv 5 155 174 10.1517/17425247.5.2.155 1:CAS:528:DC%2BD1cXhsVSju7o%3D (Pubitemid 351308309)
48. HL Wong N Chattopadhyay XY Wu R Bendayan 2010 Nanotechnology applications for improved delivery of antiretroviral drugs to the brain Adv Drug Deliv Rev 62 503 517 10.1016/j.addr.2009.11.020 1:CAS:528:DC%2BC3cXis1emtr0%3D
49. X Zhao F Pan H Xu M Yaseen H Shan CA Hauser S Zhang JR Lu 2010 Molecular self-assembly and applications of designer peptide amphiphiles Chem Soc Rev 39 3480 3498 10.1039/b915923c 1:CAS:528:DC%2BC3cXhtVehs73K